Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles.
about
Organization of research team for nano-associated safety assessment in effort to study nanotoxicology of zinc oxide and silica nanoparticlesA 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley ratsSurface modification of zinc oxide nanoparticles with amorphous silica alters their fate in the circulationComparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administrationBioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticlesEffect of zinc oxide nanoparticles on dams and embryo-fetal development in ratsBiokinetics of zinc oxide nanoparticles: toxicokinetics, biological fates, and protein interaction.Toxicity of colloidal silica nanoparticles administered orally for 90 days in rats.Prenatal development toxicity study of zinc oxide nanoparticles in rats.The effects of interfacial potential on antimicrobial propensity of ZnO nanoparticle.Endoplasmic reticulum stress and oxidative stress are involved in ZnO nanoparticle-induced hepatotoxicity.Bioavailability and biodistribution of differently charged polystyrene nanoparticles upon oral exposure in rats.Regulation of MicroRNAs, and the Correlations of MicroRNAs and Their Targeted Genes by Zinc Oxide Nanoparticles in Ovarian Granulosa Cells.Effects of Long-Term Exposure to Zinc Oxide Nanoparticles on Development, Zinc Metabolism and Biodistribution of Minerals (Zn, Fe, Cu, Mn) in Mice.The effect of ZnO nanoparticles on liver function in ratsMetal oxide nanoparticles interact with immune cells and activate different cellular responses.Dose Dependencies and Biocompatibility of Renal Clearable Gold Nanoparticles: From Mice to Non-human Primates.Ingested engineered nanomaterials: state of science in nanotoxicity testing and future research needs.Neuroinflammation is induced by tongue-instilled ZnO nanoparticles via the Ca-dependent NF-κB and MAPK pathways
P2860
Q28385170-7638683B-1D24-4A9D-BBF4-5ADD19BE0CDDQ28385176-56AF7004-F93E-4E29-A77E-6F69F6745B4BQ28386316-6C7EFB7E-B14F-4B34-9122-59D85E7C814FQ28396482-DC35EE79-22A9-4BF8-B5E8-E309EAE73505Q28397883-4F0944CD-67E9-474A-A0BC-6DCA6C14D09CQ34787862-0039142B-8C07-4EC7-A8CF-0D039F83998FQ34787922-0F562DC3-2E31-4622-90D1-C95FCAFD2CECQ34787942-9F30E590-25DC-4E01-B1DD-EE7A89874F36Q34787963-99660D74-B287-4C38-8466-1693F1E50726Q35426724-3FCC3B24-E865-4680-A4FA-B9F999C4DC76Q35561227-9F62A283-544E-42EC-9E1B-54EE7908AF4EQ35634926-71858424-F9B3-499C-8C43-39CB1EA2A286Q36022673-EAC54CDA-A02C-449B-935F-39E06D24A171Q36161596-DA190C9B-A20A-4A33-A2EA-96943EB70132Q37234673-598AC06B-15EB-46AF-A621-2AD8FA13D8E7Q41123153-8526D3B9-FCB6-4986-862F-A699A9903A96Q47827353-CBE3EC38-9950-4FD0-829F-FCF455A29582Q55517842-09943BF8-5F7F-4C1A-AB3A-7FE90561C9ACQ57811146-DB6AC32B-96F6-493B-AD16-162C96E4FD9B
P2860
Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles.
@ast
Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles.
@en
type
label
Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles.
@ast
Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles.
@en
prefLabel
Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles.
@ast
Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles.
@en
P2093
P2860
P356
P1476
Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles.
@en
P2093
Hae-Eun Chung
Jae-Min Oh
Jayoung Jeong
Jin-Ho Choy
Jong Kwon Lee
Jung-A Lee
Seung-Min Paek
Soo-Jin Choi
P2860
P304
P356
10.2147/IJN.S32593
P407
P577
2012-06-26T00:00:00Z